FlowMetric, Inc.

DOYLESTOWN, PA · Founded 2010 · Software · Still private

Software platform for water usage optimization and climate risk analysis

Claim this profile

Follows are private to you and power your alerts

Updated · flowmetric.io

Sector
Software
Headquarters
DOYLESTOWN, PA
Founded
2010
Latest Form D
$976K, Mar 2016
Total capital
$2.6M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$2.6M
4 Form D · last Mar 2016
128 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
11 pending · first 2022
Rank in peer group#331 of 2705

Capital timeline

201120122013201420152016FEDERAL ↑EQUITY ↓Cumulative $2.6M1st Form D$1.5M2nd Form D$88K3rd Form D$25K4th Form D$976K
201120122013201420152016FEDERAL ↑EQUITY ↓Cumulative $2.6M4th Form D$976K

Latest events

  • Private capital raisedForm D · SEC · 4th filing$976K
  • Private capital raisedForm D · SEC · 3rd filing$25K
  • Private capital raisedForm D · SEC · 2nd filing$88K
  • Private capital raisedForm D · SEC · 1st filing$1.5M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 2705 peers

Line = median

Software · Platform

  • Granted patents#331 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Daniel J. GambinoDirectorNamed in SEC Form D filings
  • Edward J. Giles, Jr.Executive OfficerNamed in SEC Form D filings
  • Eric J. HallbergExecutive Officer, DirectorNamed in SEC Form D filings
  • Jeremiah J. WhiteDirectorNamed in SEC Form D filings
  • John J. SoenksenDirectorNamed in SEC Form D filings
  • Raymond J. DouglasDirectorNamed in SEC Form D filings
Show all 7 people
  • Renold J. CapocasaleExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 13
Show all 13 patent records
  • Flow Cytometry System and Methods for the Diagnosis of Infectious DiseaseMar 3, 2026 · US 12,566,176Granted
  • Flow Cytometry Platform for the Detection of Glycosylated Proteins in a Clinical SampleMar 7, 2024 · Application 18270871Pending
  • Flow Cytometry System And Methods For The Diagnosis Of Infectious DiseaseNov 29, 2022 · US 11,513,119Granted
  • Systems And Methods For Determining The Risk Of Severe Allergic Reaction To Allergen, And The Immunological Protection Afforded By VaccinesDec 6, 2018 · Application 15997665Pending
  • Mobile Diagnostics Laboratory, Communications Systems, And Related MethodsJul 20, 2017 · Application 15406062Pending
  • Flow Cytometry Platform for the Detection of Glycosylated Proteins in a Clinical SampleApplication 63134318Pending
  • Detecting SARS-COV-2 And Other Infective AgentsApplication PCTUS2022014301Pending
  • Flow Cytometry System And Methods For The Diagnosis Of Infectious DiseaseApplication PCTUS2018038310Pending
  • Flow Cytometry Platform For The Detection Of Glycosylated Proteins In A Clinical SampleApplication PCTUS2022011295Pending
  • Systems And Methods For Determining The Risk Of Severe Allergic Reaction To Allergen, And The Immunological Protection Afforded By VaccinesApplication 62514794Pending
  • Systems And Methods For The Rapid Diagnosis Of Infectious DiseasesApplication 62514791Pending
  • Systems And Methods For Determining The Risk Of Severe Allergic Reaction To Allergen, And The Immunological Protection Afforded By VaccinesApplication PCTUS2018035922Pending
  • Detecting SARS-CoV-2 and Other Infective AgentsApplication 63143211Pending

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .